GO:0015755 fructose transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015755 fructose transmembrane transport describes the directed movement of fructose across cellular membranes via transporters or pores.
• The facilitative glucose transporter GLUT5 (SLC2A5) is the primary fructose-specific transporter in mammals, and key amino acids required for its function have been identified.
• Fructose transport is critical for dietary fructose absorption in the intestine and for fructose utilization in tissues such as liver, kidney, and adipose.
• Dysregulated fructose transport contributes to metabolic diseases including obesity, insulin resistance, and non-alcoholic fatty liver disease.
• Synthetic monosaccharide channels can selectively transport fructose, offering novel tools for studying and manipulating this process.
• Plant SWEET and sucrose transporters are evolutionary and functional homologs that inform our understanding of fructose transport mechanisms.
Description
Fructose transmembrane transport (GO:0015755) is the biological process by which fructose, a monosaccharide found in fruits and honey, is moved across cell membranes by dedicated transporter proteins or pores. This process is essential for the absorption of dietary fructose, its distribution among tissues, and its metabolic utilization. In mammals, fructose transport is mediated primarily by the facilitative glucose transporter GLUT5 (SLC2A5), which is highly specific for fructose and is expressed in the small intestine, kidney, and adipose tissue. The identification of essential amino acids for GLUT5-mediated fructose transport has provided mechanistic insights into how this transporter achieves substrate specificity. Beyond mammals, fructose transport systems are found in plants, where SWEET sugar transporters play critical roles in sugar allocation and stress responses. Understanding fructose transmembrane transport is therefore fundamental to metabolism, nutrition, and disease research.
fructose transmembrane transport At A Glance
| GO ID | GO:0015755 |
|---|---|
| GO term | fructose transmembrane transport |
| Ontology | biological_process |
| Synonym | fructose transport |
| Major function | Movement of fructose across membranes via transporters or pores |
| Key transporters | GLUT5 (SLC2A5), GLUT8 (SLC2A8), SWEET proteins |
| Tissue distribution | Intestine, kidney, adipose tissue, brain, and plants |
| Related diseases | Obesity, insulin resistance, non-alcoholic fatty liver disease |
What Is GO:0015755?
According to the Gene Ontology, fructose transmembrane transport (GO:0015755) is defined as the directed movement of fructose into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Fructose exists in an open chain form or as a ring compound, and D-fructose is the sweetest of the sugars, found free in many fruits and honey. This process encompasses both facilitated diffusion and active transport mechanisms that enable fructose to cross lipid bilayers, which are otherwise impermeable to sugars.
Why Is fructose transmembrane transport Important in Cell Biology?
Fructose transmembrane transport is central to energy homeostasis and metabolic health. In mammals, the uptake of dietary fructose is mediated by GLUT5 in the intestine, and its subsequent transport into tissues such as liver and adipose is critical for lipogenesis and energy storage. Dysregulation of fructose transport has been linked to metabolic disorders, including obesity, insulin resistance, and non-alcoholic fatty liver disease. In plants, fructose transport via SWEET proteins is essential for seed filling, nectar secretion, and pathogen susceptibility. Moreover, synthetic channels that selectively transport fructose provide new tools for probing and potentially correcting transport defects. Thus, understanding this process has broad implications for human health, agriculture, and biotechnology.
• Dietary fructose absorption in the small intestine depends on GLUT5-mediated transport.
• Fructose transport into the liver contributes to de novo lipogenesis and may promote fatty liver disease.
• GLUT5 is a potential therapeutic target for managing fructose-related metabolic disorders.
• Fructose transport in the kidney is important for reabsorption and maintaining blood fructose levels.
• In the brain, fructose transport may influence neuronal metabolism and signaling.
• Plant SWEET transporters mediate fructose efflux and are critical for development and stress responses.
• Synthetic monosaccharide channels can mimic or modulate fructose transport for research and therapeutic applications.
• Understanding fructose transport aids in the development of nutritional strategies and drugs for metabolic syndrome.
• Fructose transport is a model system for studying solute carrier (SLC) transporter structure-function relationships.
• Comparative studies of plant and animal fructose transporters reveal evolutionary adaptations in sugar transport.
What Happens During fructose transmembrane transport?
Substrate Recognition and Binding
In simple terms: The transporter first recognizes and grabs fructose from one side of the membrane.
Fructose transmembrane transport begins with the specific binding of fructose to a transporter protein. For GLUT5, this involves a conformational state that accommodates the fructose molecule, which can exist in open chain or ring forms. Mutagenesis studies have identified essential amino acids within the GLUT5 binding pocket that are required for fructose recognition and transport, distinguishing it from glucose transporters. In plants, SWEET transporters recognize fructose with varying affinities, enabling selective distribution.
Conformational Change and Translocation
In simple terms: The transporter changes shape to carry fructose across the membrane.
After binding, the transporter undergoes a conformational change that moves fructose from the extracellular to the intracellular side of the membrane. This alternating access mechanism is characteristic of facilitative transporters like GLUT5, which do not require ATP but rely on concentration gradients. The process is reversible, allowing fructose to move down its concentration gradient. Structural and functional studies of GLUT5 have revealed that specific residues are critical for this translocation step.
Release and Cellular Utilization
In simple terms: Once inside, fructose is released and can be used by the cell.
Upon reaching the cytoplasmic side, fructose is released from the transporter and becomes available for metabolic pathways such as glycolysis, gluconeogenesis, and lipogenesis. In enterocytes, fructose exits via GLUT2 or other transporters to enter the portal circulation. In hepatocytes, fructose is rapidly phosphorylated by fructokinase and metabolized. The transport step is often rate-limiting for fructose utilization, making it a key regulatory point.
Regulation by Hormones and Nutrients
In simple terms: The amount of fructose transport can go up or down based on the body's needs.
Fructose transport is regulated at multiple levels. GLUT5 expression in the intestine is induced by dietary fructose and hormones such as glucocorticoids and thyroid hormone. In adipose tissue, insulin can influence GLUT5 trafficking. In plants, SWEET transporter activity is regulated by phosphorylation and interaction with other proteins. This regulation ensures that fructose uptake matches metabolic demand and prevents excessive fructose accumulation.
Key Genes Involved in GO:0015755 fructose transmembrane transport
The following genes encode proteins directly involved in fructose transmembrane transport or its regulation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC2A5 (GLUT5) | Primary fructose transporter in mammals; mediates facilitated diffusion of fructose | Key target for studying fructose absorption and metabolic disease |
| SLC2A2 (GLUT2) | Bidirectional transporter for glucose and fructose; facilitates fructose exit from enterocytes | Important for fructose absorption and blood fructose homeostasis |
| SLC2A8 (GLUT8) | Intracellular hexose transporter; may transport fructose in specific tissues | Less characterized; potential role in brain and testis fructose transport |
| SLC2A9 (GLUT9) | Urate transporter; also transports fructose in kidney and liver | Linked to uric acid metabolism and fructose-induced hyperuricemia |
| SLC2A10 (GLUT10) | Dehydroascorbate and fructose transporter | Mutations cause arterial tortuosity syndrome; fructose transport may contribute |
| SLC2A11 (GLUT11) | Fructose and glucose transporter | Expressed in heart and muscle; role in fructose utilization |
| SLC2A12 (GLUT12) | Insulin-responsive glucose/fructose transporter | Potential role in fructose uptake in muscle and adipose |
| SLC2A13 (GLUT13) | Myo-inositol transporter; may also transport fructose | Brain-specific; possible role in fructose sensing |
| SWEET1 | Plant fructose efflux transporter | Model for studying sugar transport in plants |
| SWEET2 | Vacuolar fructose transporter | Involved in sugar storage and stress response |
| SWEET4 | Fructose and glucose transporter in plants | Important for seed development and pathogen susceptibility |
| SWEET11 | Sucrose transporter; indirectly affects fructose distribution | Key for phloem loading and grain filling |
| SWEET16 | Vacuolar sugar transporter | Regulates fructose levels in vacuoles |
| SUT1 | Sucrose transporter in plants | Influences fructose availability via sucrose cleavage |
| SUT2 | Sucrose transporter in sweet potato | Affects fructose accumulation in storage roots |
| HK (Hexokinase) | Phosphorylates fructose after transport | Links transport to metabolism; feedback regulation |
| KHK (Fructokinase) | Phosphorylates fructose in liver | Critical for fructose metabolism; mutations cause fructosuria |
How Is fructose transmembrane transport Regulated?
Fructose transmembrane transport is regulated at transcriptional, post-transcriptional, and post-translational levels. In mammals, GLUT5 (SLC2A5) expression in the small intestine is induced by dietary fructose, and this induction is mediated by transcription factors such as ChREBP and SREBP-1c. Hormones including glucocorticoids, thyroid hormone, and insulin modulate GLUT5 and GLUT2 trafficking and activity. In adipose tissue, insulin stimulates GLUT5 translocation to the plasma membrane. In plants, SWEET transporter activity is regulated by phosphorylation and protein-protein interactions, and their expression is influenced by developmental and environmental cues. Additionally, synthetic channels can be engineered to regulate fructose transport selectively.
fructose transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC2A5 (GLUT5) | Obesity, insulin resistance, NAFLD | Intestinal-specific KO mice; high-fructose diet challenge |
| SLC2A2 (GLUT2) | Fanconi-Bickel syndrome; fructose intolerance | Liver-specific KO; glucose/fructose tolerance tests |
| SLC2A9 (GLUT9) | Hyperuricemia, gout | Kidney-specific KO; uric acid and fructose loading |
| SLC2A10 (GLUT10) | Arterial tortuosity syndrome | Patient-derived fibroblasts; fructose transport assays |
| KHK (Fructokinase) | Hereditary fructosuria | KHK KO mice; fructose metabolism studies |
Fructose Transport in Metabolic Disease
Excessive fructose consumption and enhanced fructose transport contribute to metabolic syndrome, obesity, and non-alcoholic fatty liver disease (NAFLD). GLUT5-mediated fructose uptake in the intestine and subsequent transport to the liver drives de novo lipogenesis, leading to hepatic steatosis and insulin resistance. Elevated fructose transport in adipose tissue also promotes adipogenesis and inflammation. Therefore, targeting fructose transporters is a potential therapeutic strategy for metabolic disorders.
Fructose Transport and Cancer
Cancer cells often exhibit altered sugar metabolism, and fructose can serve as an alternative carbon source. GLUT5 is overexpressed in some cancers, including breast and prostate cancer, where it enhances fructose uptake and supports proliferation. Knockdown of GLUT5 reduces fructose transport and tumor growth in preclinical models, suggesting that fructose transport is a metabolic vulnerability in cancer.
Fructose Transport in Neurological Disorders
The brain expresses GLUT5 and other fructose transporters, and fructose metabolism may influence neuronal function. In conditions such as Alzheimer's disease and ischemia, altered fructose transport could affect energy supply and oxidative stress. However, the exact role of fructose transport in neurodegeneration remains under investigation, and further studies are needed to establish causality.
From fructose transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GLUT5 mediate fructose uptake in vivo? | Intestinal epithelial cell-specific GLUT5 knockout mice |
| Which amino acids are essential for GLUT5 transport? | Site-directed mutagenesis and overexpression in HEK293 cells |
| Can fructose transport be selectively modulated? | Synthetic monosaccharide channels in liposomes or cells |
| How does fructose transport affect liver lipid metabolism? | Hepatocyte-specific GLUT2/GLUT5 double knockout mice |
| What is the role of SWEET transporters in plant development? | Arabidopsis SWEET mutants and overexpression lines |
| Does fructose transport contribute to cancer growth? | Xenograft models with GLUT5 knockdown or overexpression |
How to Study the fructose transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled fructose uptake | Transport rate and kinetics | GLUT5 function in cells |
| RNA-seq | Transcript levels of transporters | Tissue-specific expression profiling |
| Western blot | Protein expression and modification | GLUT5 regulation by diet |
| Immunofluorescence | Subcellular localization | Membrane trafficking of transporters |
| CRISPR knockout | Loss-of-function phenotype | Causal role of GLUT5 in fructose uptake |
| Site-directed mutagenesis | Amino acid function | Identification of essential residues |
| Synthetic channels | Selective transport | Engineering artificial fructose transporters |
| Metabolic flux analysis | Fructose utilization | Liver lipogenesis studies |
Transport Assays
Fructose transport activity is commonly measured using radiolabeled 14C-fructose or fluorescent fructose analogs in cultured cells or isolated membrane vesicles. For GLUT5, heterologous expression in Xenopus oocytes or HEK293 cells followed by uptake assays is standard. These assays allow determination of kinetic parameters (Km, Vmax) and inhibitor sensitivity.
Gene Expression Analysis
RNA-seq and quantitative RT-PCR are used to measure mRNA levels of fructose transporters (e.g., SLC2A5, SLC2A2) in tissues or cells under different conditions. This helps identify transcriptional regulation by diet, hormones, or disease states. Single-cell RNA-seq can reveal cell-type-specific expression patterns.
Protein Detection and Localization
Western blotting and immunofluorescence microscopy are used to detect transporter protein levels and subcellular localization. For example, GLUT5 trafficking to the plasma membrane can be visualized using tagged constructs or specific antibodies. Proximity ligation assays can identify interacting partners.
Genetic Manipulation
CRISPR-Cas9 knockout, knock-in, and overexpression models are powerful tools to study fructose transport. Knockout of SLC2A5 in mice or cell lines abolishes fructose uptake, while knock-in of point mutations can dissect structure-function relationships. These models are essential for establishing causality in disease.
How CRISPR Can Be Used to Study GO:0015755 fructose transmembrane transport
Knockout
CRISPR-Cas9 knockout of fructose transporter genes (e.g., SLC2A5) is used to abolish fructose transport and study its physiological consequences. For example, GLUT5 knockout mice exhibit reduced intestinal fructose absorption and are protected from fructose-induced fatty liver. In cell lines, knockout of SLC2A5 eliminates fructose uptake, confirming its role as the primary fructose transporter.
Point Mutation
Point mutations introduced by CRISPR base editing or homology-directed repair can dissect the function of specific amino acids in fructose transporters. Mutagenesis of GLUT5 has identified residues critical for fructose binding and translocation, and such mutants can be expressed in cells to measure transport activity. This approach helps validate structural models and identify disease-associated variants.
Knock-in
Knock-in of tagged transporters (e.g., GFP-GLUT5) allows real-time visualization of trafficking and localization. Knock-in of disease-associated mutations (e.g., in SLC2A10) can model arterial tortuosity syndrome and study fructose transport defects. These models are valuable for drug screening and mechanistic studies.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of fructose transporters increases fructose uptake capacity. Overexpression of GLUT5 in cell lines enhances fructose transport and can be used to study downstream metabolic effects, such as lipogenesis. In plants, overexpression of SWEET transporters alters sugar distribution and can improve yield.
How EDITGENE Supports fructose transmembrane transport Research
Researchers studying fructose transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in fructose uptake, metabolism, or disease. Establishing causality requires precise genetic manipulation, such as knockout, point mutation, knock-in, or overexpression of the gene of interest. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from custom cell line generation to high-throughput library screening and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for fructose transmembrane transport research.
Frequently Asked Questions About fructose transmembrane transport
What is fructose transmembrane transport?
Fructose transmembrane transport (GO:0015755) is the process by which fructose moves across cell membranes via specific transporter proteins or pores, as defined by the Gene Ontology.
What genes are involved in fructose transmembrane transport?
Key genes include SLC2A5 (GLUT5), SLC2A2 (GLUT2), SLC2A8 (GLUT8), and plant SWEET transporters, among others.
Which transporter is specific for fructose?
GLUT5 (SLC2A5) is the primary fructose-specific facilitative transporter in mammals.
How is fructose transported into cells?
Fructose is transported by facilitated diffusion via GLUT5 and other transporters, moving down its concentration gradient without direct ATP consumption.
What diseases are associated with fructose transport?
Dysregulated fructose transport is linked to obesity, insulin resistance, non-alcoholic fatty liver disease, and some cancers.
Can fructose transport be studied using CRISPR?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to study the function of fructose transporters and their role in disease.
What are SWEET transporters?
SWEET transporters are plant proteins that mediate the efflux of sugars, including fructose, and are important for development and stress responses.
How is GLUT5 regulated?
GLUT5 expression is induced by dietary fructose and hormones such as glucocorticoids and thyroid hormone, and its trafficking can be modulated by insulin.
Are there synthetic fructose channels?
Yes, synthetic monosaccharide channels such as porphyrin boxes can selectively transport fructose across membranes, providing new research tools.
What methods measure fructose transport?
Radiolabeled fructose uptake assays, fluorescent analogs, and electrophysiology are commonly used to measure transport activity.
Conclusion
Fructose transmembrane transport (GO:0015755) is a fundamental biological process with far-reaching implications for metabolism, nutrition, and disease. The identification of specific transporters like GLUT5 and their regulatory mechanisms has advanced our understanding of fructose homeostasis and its contribution to metabolic disorders. Continued research using CRISPR-based models and synthetic biology tools will further elucidate the roles of fructose transport in health and disease, potentially leading to new therapeutic strategies.
References
- 1. Filali-Mouncef Y et al.. 2022. The ménage à trois of autophagy, lipid droplets and liver disease.. Autophagy 18(1):50-72 PMID: 33794741
- 2. Lee HG et al.. 2023. Synthetic Monosaccharide Channels: Size-Selective Transmembrane Transport of Glucose and Fructose Mediated by Porphyrin Boxes.. Angew Chem Int Ed Engl 62(2):e202214326 PMID: 36382990
- 3. Selinger M et al.. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.. Comput Struct Biotechnol J 20:2759-2777 PMID: 35685361
- 4. Mueckler M. 1994. Facilitative glucose transporters.. Eur J Biochem 219(3):713-25 PMID: 8112322
- 5. Ebert K et al.. 2018. Identification of essential amino acids for glucose transporter 5 (GLUT5)-mediated fructose transport.. J Biol Chem 293(6):2115-2124 PMID: 29259131
- 6. Li X et al.. 2025. Evolutionary trajectory and functional diversity of SWEET sugar transporters in plants.. Plant J 123(1):e70334 PMID: 40628238
- 7. Schmidt S et al.. 2009. GLUT8, the enigmatic intracellular hexose transporter.. Am J Physiol Endocrinol Metab 296(4):E614-8 PMID: 19176349
- 8. Liu Y et al.. 2023. [Functional analysis on sucrose transporters in sweet potato].. Sheng Wu Gong Cheng Xue Bao 39(7):2772-2793 PMID: 37584131
